These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2692496)

  • 1. [Prevention of venous thrombosis in paraplegic patients. An open study of fraxiparin].
    Yelnik A; Denys P; Schouman-Claeys E; Frija G; Held JP
    Ann Med Interne (Paris); 1989; 140(7):647. PubMed ID: 2692496
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and tolerance of the low molecular weight heparin fraction CY 216 in preventing postoperative venous thromboembolism].
    Kakkar VV
    Med Klin Suppl; 1986 Oct; 3():13-6. PubMed ID: 3550366
    [No Abstract]   [Full Text] [Related]  

  • 3. [Do the prevention and treatment of deep venous thrombosis have specificity in the cancer patient?].
    Voog E
    Bull Cancer; 1998 Jul; 85(7):618-21. PubMed ID: 9752268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk and prevention of venous thromboembolic complications in surgery].
    Baeshko AA
    Khirurgiia (Mosk); 2001; (4):61-9. PubMed ID: 11490498
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of deep venous thrombosis in surgical patients].
    Marshall M
    Med Klin Suppl; 1986 Oct; 3():11-3. PubMed ID: 3470588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of heparin and oral anticoagulants to prevent and treat deep venous thrombosis and pulmonary embolism].
    Hamerschlak N; Rosenfeld LG
    Arq Bras Cardiol; 1996 Sep; 67(3):209-13. PubMed ID: 9181717
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA
    Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of anticoagulant therapy in deep venous thrombosis].
    Nielsen HK; Geday E; Bechgaard P; Husted SE
    Ugeskr Laeger; 1981 Jul; 143(31):1947-51. PubMed ID: 7029841
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanisms of venous thrombosis. Anticoagulants, aspirin, and heparin.
    O'Brien JR
    Mod Concepts Cardiovasc Dis; 1973 Mar; 42(3):11-5. PubMed ID: 4572065
    [No Abstract]   [Full Text] [Related]  

  • 11. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J; Crowther M
    Thromb Haemost; 1997 Jul; 78(1):689-92. PubMed ID: 9198240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of surgical treatment of acute ileofemoral venous thrombosis with subsequent fibrinolysin and anticoagulant therapy].
    Koniukhov SG
    Vestn Khir Im I I Grek; 1966 Jun; 96(6):6-9. PubMed ID: 4233823
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of deep vein thrombosis of the lower limb: a comparison of arvin (Ancrod) and heparin by a double-blind technique.
    Davies JA; Merrick MV; Sharp AA; Holt JM
    Br J Haematol; 1972 May; 22(5):640. PubMed ID: 4555717
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of postoperative deep venous thrombosis. Low-dose heparin versus graded pressure stockings.
    Fasting H; Andersen K; Kraemmer Nielsen H; Husted SE; Koopmann HD; Simonsen O; Husegaard HC; Vestergaard Madsen J; Pedersen TK
    Acta Chir Scand; 1985; 151(3):245-8. PubMed ID: 3892994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD
    Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unusual cause of leg venous thrombosis in a 20-year-old man].
    Ziegler T; Winkler C
    Wien Klin Wochenschr; 2000 Dec; 112(24):1039. PubMed ID: 11204313
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ambulatory treatment of deep venous thrombosis with Fraxiparin. Study of 58 cases].
    Bellenger L
    J Mal Vasc; 1990; 15(4):399-400. PubMed ID: 2286825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.